Media coverage
14
Media coverage
Title DecisionDx®-Melanoma Outperforms Memorial Sloan Kettering Cancer Center (MSKCC) Nomogram in Predicting Sentinel Lymph Node Positivity in Patients with Cutaneous Melanoma Media name/outlet Business Wire Country/Territory United States Date 5/10/23 URL ct.moreover.com/?a=51982794618&p=1gw&v=1&x=RYsTVw9AUIiASZx-3zWPMQ Persons Michael Tassavor Title DecisionDx®-Melanoma Outperforms Memorial Sloan Kettering Cancer Center (MSKCC) Nomogram in Predicting Sentinel Lymph Node Positivity in Patients with Cutaneous Melanoma; Study shows the DecisionDx-Melanoma test identifies more patients who can safely for Media name/outlet Business Wire Country/Territory United States Date 5/10/23 Persons Michael Tassavor Title DecisionDx®-Melanoma Outperforms Memorial Sloan Kettering Cancer Center (MSKCC) Nomogram in Predicting Sentinel Lymph Node Positivity in Patients with Cutaneous Melanoma Media name/outlet BioSpace Country/Territory United States Date 5/10/23 URL ct.moreover.com/?a=51983455786&p=1gw&v=1&x=mD0ojXRrLYpQ3KAGsOODvg Persons Michael Tassavor Title DecisionDx®-Melanoma Outperforms Memorial Sloan Kettering Cancer Center (MSKCC) Nomogram in Predicting Sentinel Lymph Node Positivity in Patients with Cutaneous Melanoma Media name/outlet InvestorsObserver Country/Territory United States Date 5/10/23 URL ct.moreover.com/?a=51982784524&p=1gw&v=1&x=zXf0ChEPNn6x_mFlHl-9Ew Persons Michael Tassavor Title DecisionDx®-Melanoma Outperforms Memorial Sloan Kettering Cancer Center (MSKCC) Nomogram in Predicting Sentinel Lymph Node Positivity in Patients with Cutaneous Melanoma Media name/outlet ADVFN UK Country/Territory United Kingdom Date 5/10/23 URL ct.moreover.com/?a=51982797874&p=1gw&v=1&x=OSD83NFJyf4ROi9xIwfinA Persons Michael Tassavor Title DecisionDx®-Melanoma Outperforms Memorial Sloan Kettering Cancer Center (MSKCC) Nomogram in Predicting Sentinel Lymph Node Positivity in Patients with Cutaneous Melanoma Media name/outlet Finanzen.net Country/Territory Germany Date 5/10/23 URL ct.moreover.com/?a=51982801879&p=1gw&v=1&x=GmUgUOnIopv4-Q8e2tdeww Persons Michael Tassavor Title DecisionDx®-Melanoma Outperforms Memorial Sloan Kettering Cancer Center (MSKCC) Nomogram in Predicting Sentinel Lymph Node Positivity in Patients with Cutaneous Melanoma Media name/outlet Yahoo! Finance Country/Territory United States Date 5/10/23 URL ct.moreover.com/?a=51982848415&p=1gw&v=1&x=uytqx-dzLlCpu1r5bRQe0A Persons Michael Tassavor Title DecisionDx®-Melanoma Outperforms Memorial Sloan Kettering Cancer Center (MSKCC) Nomogram in Predicting Sentinel Lymph Node Positivity in Patients with Cutaneous Melanoma Media name/outlet Finanzen.ch Country/Territory Switzerland Date 5/10/23 URL ct.moreover.com/?a=51982870002&p=1gw&v=1&x=BxY84DG2XgtFYFkycs-TUw Persons Michael Tassavor Title DecisionDx®-Melanoma Outperforms Memorial Sloan Kettering Cancer Center (MSKCC) Nomogram in Predicting Sentinel Lymph Node Positivity in Patients with Cutaneous Melanoma Media name/outlet MarketScreener.com Country/Territory United States Date 5/10/23 URL ct.moreover.com/?a=51983370973&p=1gw&v=1&x=U85VZA9N5Sk7UssZFroP4A Persons Michael Tassavor Title DecisionDx®-Melanoma Outperforms Memorial Sloan Kettering Cancer Center (MSKCC) Nomogram in Predicting Sentinel Lymph Node Positivity in Patients with Cutaneous Melanoma Media name/outlet Le Lezard.com Country/Territory Canada Date 5/10/23 URL ct.moreover.com/?a=51982799755&p=1gw&v=1&x=Jsmn01nMUDZMZedNqDudnA Persons Michael Tassavor Title $CSTL DecisionDx®-Melanoma Outperforms Memorial Sloan Kettering Cancer Center (MSKCC) Nomogram in Predicting Sentinel Lymph Node Positivity in Patients with Cutaneous Melanoma Media name/outlet OTC Dynamics Country/Territory Canada Date 5/10/23 URL ct.moreover.com/?a=51983583772&p=1gw&v=1&x=DzduUrroBpDKaE1vtIuNpg Persons Michael Tassavor Title DecisionDx®-Melanoma Outperforms Memorial Sloan Kettering Cancer Center (MSKCC) Nomogram in Predicting Sentinel Lymph Node Positivity in Patients with Cutaneous Melanoma Media name/outlet Bakersfield.com Country/Territory United States Date 5/10/23 URL ct.moreover.com/?a=51982860245&p=1gw&v=1&x=Ft73V3j7L5mSDUS6AM2Czw Persons Michael Tassavor Title DecisionDx®-Melanoma Outperforms Memorial Sloan Kettering Cancer Center (MSKCC) Nomogram in Predicting Sentinel Lymph Node Positivity in Patients with Cutaneous Melanoma Media name/outlet Valdosta Daily Times Country/Territory Georgia Date 5/10/23 URL ct.moreover.com/?a=51982969351&p=1gw&v=1&x=QYsFY0ePm_17P20ZxZ8JbQ Persons Michael Tassavor Title DecisionDx®-Melanoma Outperforms Memorial Sloan Kettering Cancer Center (MSKCC) Nomogram in Predicting Sentinel Lymph Node Positivity in Patients with Media name/outlet Acrofan Date 4/10/23 URL ct.moreover.com/?a=51982999018&p=1gw&v=1&x=MFI23VLgwjf1KRoxaKHHzg Persons Michael Tassavor